285 related articles for article (PubMed ID: 9881865)
1. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase.
Watts PM; Riedl AG; Douek DC; Edwards RJ; Boobis AR; Jenner P; Marsden CD
Neuroscience; 1998 Sep; 86(2):511-9. PubMed ID: 9881865
[TBL] [Abstract][Full Text] [Related]
2. Expression and distribution of CYP2C enzymes in rat basal ganglia.
Riedl AG; Watts PM; Douek DC; Edwards RJ; Boobis AR; Rose S; Jenner P
Synapse; 2000 Dec; 38(4):392-402. PubMed ID: 11044886
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of cytochrome P450 enzymes in cultured and intact foetal rat ventral mesencephalon.
Gilbert EA; Edwards RJ; Boobis AR; Rose S; Jenner P
J Neural Transm (Vienna); 2003 Oct; 110(10):1091-101. PubMed ID: 14523622
[TBL] [Abstract][Full Text] [Related]
4. Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera.
Riedl AG; Watts PM; Edwards RJ; Boobis AR; Jenner P; Marsden CD
Brain Res; 1996 Dec; 743(1-2):324-8. PubMed ID: 9017262
[TBL] [Abstract][Full Text] [Related]
5. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata.
Yung KK; Tse YC; Gao ZG; Choi SY; Kwok FS
Neurosci Lett; 1998 Aug; 253(1):57-60. PubMed ID: 9754804
[TBL] [Abstract][Full Text] [Related]
6. Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons.
Tepper JM; Damlama M; Trent F
Neuroscience; 1994 May; 60(2):469-77. PubMed ID: 7915412
[TBL] [Abstract][Full Text] [Related]
7. Expression and localisation of CYP2D enzymes in rat basal ganglia.
Riedl AG; Watts PM; Edwards RJ; Schulz-Utermoehl T; Boobis AR; Jenner P; Marsden CD
Brain Res; 1999 Mar; 822(1-2):175-91. PubMed ID: 10082895
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study.
Bolam JP; Francis CM; Henderson Z
Neuroscience; 1991; 41(2-3):483-94. PubMed ID: 1678502
[TBL] [Abstract][Full Text] [Related]
9. Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
Thibaut F; Faucheux BA; Marquez J; Villares J; Menard JF; Agid Y; Hirsch EC
Brain Res; 1995 Sep; 692(1-2):233-43. PubMed ID: 8548309
[TBL] [Abstract][Full Text] [Related]
10. Striatal infarction in the rat causes a transient reduction of tyrosine hydroxylase immunoreactivity in the ipsilateral substantia nigra.
Soriano MA; Justicia C; Ferrer I; Rodríguez-Farré E; Planas AM
Neurobiol Dis; 1997; 4(5):376-85. PubMed ID: 9440126
[TBL] [Abstract][Full Text] [Related]
11. Intrapallidal lipopolysaccharide injection increases iron and ferritin levels in glia of the rat substantia nigra and induces locomotor deficits.
Zhang J; Stanton DM; Nguyen XV; Liu M; Zhang Z; Gash D; Bing G
Neuroscience; 2005; 135(3):829-38. PubMed ID: 16165292
[TBL] [Abstract][Full Text] [Related]
12. Localization of ionotropic and metabotropic glutamate receptors in distinct neuronal elements of the rat substantia nigra.
Yung KK
Neurochem Int; 1998 Oct; 33(4):313-26. PubMed ID: 9840222
[TBL] [Abstract][Full Text] [Related]
13. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
14. Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
Thibaut F; Hirsch EC; Raisman R; Javoy-Agid F; Agid Y
Neuroscience; 1990; 37(2):387-98. PubMed ID: 1983469
[TBL] [Abstract][Full Text] [Related]
15. Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.
Iravani MM; Kashefi K; Mander P; Rose S; Jenner P
Neuroscience; 2002; 110(1):49-58. PubMed ID: 11882372
[TBL] [Abstract][Full Text] [Related]
16. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
[TBL] [Abstract][Full Text] [Related]
17. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
18. Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time-course, distribution, and morphology of cell death.
Stefanis L; Burke RE
Neuroscience; 1996 Oct; 74(4):997-1008. PubMed ID: 8895868
[TBL] [Abstract][Full Text] [Related]
19. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons.
Burke RE; Macaya A; DeVivo D; Kenyon N; Janec EM
Neuroscience; 1992 Oct; 50(3):559-69. PubMed ID: 1359461
[TBL] [Abstract][Full Text] [Related]
20. Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats.
He Y; Lee T; Leong SK
Neuroscience; 1999; 91(2):579-85. PubMed ID: 10366015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
